ID21014A - Modifikasi kristal dari zat farmasi - Google Patents

Modifikasi kristal dari zat farmasi

Info

Publication number
ID21014A
ID21014A IDW980066D ID980066D ID21014A ID 21014 A ID21014 A ID 21014A ID W980066 D IDW980066 D ID W980066D ID 980066 D ID980066 D ID 980066D ID 21014 A ID21014 A ID 21014A
Authority
ID
Indonesia
Prior art keywords
pharmaceuticals
crystal modification
crystal
modification
Prior art date
Application number
IDW980066D
Other languages
English (en)
Indonesian (id)
Inventor
Robert Portmann
Urs Christoph Hofmeier
Andreas Burkhard
Walter Scherrer
Martin Szelagiewicz
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=4209650&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID21014(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of ID21014A publication Critical patent/ID21014A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IDW980066D 1997-06-10 1998-06-08 Modifikasi kristal dari zat farmasi ID21014A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH140497 1997-06-10

Publications (1)

Publication Number Publication Date
ID21014A true ID21014A (id) 1999-04-08

Family

ID=4209650

Family Applications (2)

Application Number Title Priority Date Filing Date
IDW980066D ID21014A (id) 1997-06-10 1998-06-08 Modifikasi kristal dari zat farmasi
IDW980065D ID27660A (id) 1997-06-10 1998-06-08 Modifikasi kristal dari zat farmasi

Family Applications After (1)

Application Number Title Priority Date Filing Date
IDW980065D ID27660A (id) 1997-06-10 1998-06-08 Modifikasi kristal dari zat farmasi

Country Status (36)

Country Link
US (6) US6740669B1 (cs)
EP (2) EP0994864B1 (cs)
JP (2) JP3672574B2 (cs)
KR (2) KR100425656B1 (cs)
CN (3) CN1159300C (cs)
AR (4) AR012946A1 (cs)
AT (2) ATE232852T1 (cs)
AU (2) AU725528B2 (cs)
BR (2) BR9804946A (cs)
CA (3) CA2256013C (cs)
CO (2) CO4940452A1 (cs)
CY (1) CY2007014I1 (cs)
CZ (2) CZ292481B6 (cs)
DE (3) DE69813560T2 (cs)
DK (2) DK0994864T3 (cs)
ES (2) ES2197485T3 (cs)
FR (1) FR07C0037I2 (cs)
HU (2) HU225153B1 (cs)
ID (2) ID21014A (cs)
IL (2) IL125732A (cs)
LU (1) LU91345I2 (cs)
MY (2) MY125854A (cs)
NL (1) NL300284I2 (cs)
NO (2) NO329314B1 (cs)
NZ (2) NZ331371A (cs)
PE (2) PE79799A1 (cs)
PL (2) PL191943B1 (cs)
PT (1) PT994864E (cs)
RU (2) RU2198167C2 (cs)
SI (2) SI0994863T1 (cs)
SK (2) SK283734B6 (cs)
TR (2) TR199801631T1 (cs)
TW (2) TW403740B (cs)
UY (1) UY25844A1 (cs)
WO (2) WO1998056773A1 (cs)
ZA (2) ZA984966B (cs)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW403740B (en) * 1997-06-10 2000-09-01 Novartis Ag Novel crystal modifications of the compound 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide
MXPA04011865A (es) * 2002-05-31 2005-03-31 Schering Corp Polimorfos inhibidores de xantina fosfodiesterasa v.
GB0507298D0 (en) 2005-04-11 2005-05-18 Novartis Ag Organic compounds
US7875284B2 (en) * 2006-03-10 2011-01-25 Cook Incorporated Methods of manufacturing and modifying taxane coatings for implantable medical devices
US20090069390A1 (en) * 2007-09-12 2009-03-12 Protia, Llc Deuterium-enriched rufinamide
NZ591725A (en) * 2008-10-13 2012-09-28 Cipla Ltd PROCESS FOR THE PREPARATION OF RUFINAMIDE which is also known as 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide
CN101768124B (zh) * 2008-12-30 2012-01-04 北京本草天源药物研究院 一种药物晶体及其制备方法和用途
IT1395736B1 (it) 2009-08-04 2012-10-19 Dipharma Francis Srl Forme cristalline di rufinamide
MX2012002730A (es) * 2009-09-04 2012-07-20 Tactical Therapeutics Inc Nuevas composiciones y procesos para preparar formulaciones de 1,2,3-triazoles 5-amino o amino sustituidos y triazol orotato.
EP2727914A1 (en) 2010-04-30 2014-05-07 Laboratorios Lesvi, S.L. Polymorph of 1-(2,6-difluorobenzyl)-1h-1,2,3-triazole-carboxamide
EP2465853A1 (en) 2010-12-14 2012-06-20 Laboratorios Lesvi, S.L. Polymorph of rufinamide and process for obtaining it
ITMI20110718A1 (it) 2011-04-29 2012-10-30 Dipharma Francis Srl Procedimento per la purificazione di rufinamide
WO2014013511A2 (en) * 2012-07-20 2014-01-23 Hetero Research Foundation Rufinamide solid dispersion
WO2021099481A1 (en) 2019-11-20 2021-05-27 Medichem, S.A. Solid composition containing rufinamide

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3992378A (en) 1973-12-26 1976-11-16 Eli Lilly And Company Fluoralkyl quinoxadinediones
US4156734A (en) 1976-02-13 1979-05-29 Merck & Co., Inc. Antihypertensive compositions containing an aryl-substituted alanine azo and an arylhydrazino-propionic acid
GB1511195A (en) 1976-10-18 1978-05-17 Ici America Inc Triazole derivatives
US4536518A (en) 1979-11-01 1985-08-20 Pfizer Inc. Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine
US4346097A (en) * 1980-09-30 1982-08-24 Warner-Lambert Company Method for treating convulsions with pyrazole-4-carboxamide derivatives
FI834666A7 (fi) 1982-12-23 1984-06-24 Ciba Geigy Ag Foerfarande foer framstaellning av nya aralkyltriazolfoereningar.
US4789680A (en) * 1982-12-23 1988-12-06 Ciba-Geigy Corporation Aralkyltriazole compounds
US4511572A (en) * 1983-03-18 1985-04-16 The University Of Kentucky Research Foundation Triazoline anticonvulsant drugs
PH22568A (en) * 1985-04-18 1988-10-17 Ciba Geigy Ag Fluorinated benzyl triazoles and pharmaceutical compositions containing the same
CA2002864C (en) 1988-11-29 1999-11-16 Eddy J. E. Freyne (1h-azol-1-ylmethyl) substituted quinoline, quinazoline or quinoxaline derivatives
JPH02214504A (ja) 1989-02-15 1990-08-27 Nissan Chem Ind Ltd 光学活性キノキサリン化合物の晶析法
EP0484437A4 (en) 1989-07-27 1994-06-01 Searle & Co Renal-selective prodrugs for the treatment of hypertension
IL96507A0 (en) 1989-12-08 1991-08-16 Merck & Co Inc Nitrogen-containing spirocycles and pharmaceutical compositions containing them
CA2095444C (en) 1990-11-06 2001-06-19 Shuichi Sakamoto Fused pyrazine derivatives
JP2753911B2 (ja) 1991-12-06 1998-05-20 キッセイ薬品工業株式会社 Ｎ−ｔｅｒｔ−ブチル−１−メチル−３，３−ジフェニルプロピルアミン塩酸塩の結晶多形およびその製造方法
DE4217952A1 (de) 1992-05-30 1993-12-02 Basf Ag Chinoxalin-2,3(1H,4H)-dione
US5248699A (en) 1992-08-13 1993-09-28 Pfizer Inc. Sertraline polymorph
US5631373A (en) 1993-11-05 1997-05-20 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon, Eugene Oregon Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones
GB9418443D0 (en) 1994-09-13 1994-11-02 Pfizer Ltd Therapeutic agents
GB9419318D0 (en) 1994-09-24 1994-11-09 Pfizer Ltd Therapeutic agents
KR100419355B1 (ko) 1995-02-22 2004-06-04 훽스트파마슈티칼스앤드케미칼스가부시키가이샤 무정형피레타나이드,피레타나이드다형체,이들의제조방법및이를포함하는약제학적조성물
CA2260065C (en) * 1996-07-11 2006-10-17 Novartis Ag Process for preparing 1-substituted 4-cyano-1,2,3-triazoles
TW403740B (en) * 1997-06-10 2000-09-01 Novartis Ag Novel crystal modifications of the compound 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide

Also Published As

Publication number Publication date
EP0994863B1 (en) 2003-02-19
EP0994864B1 (en) 2003-04-16
DE122007000051I2 (de) 2009-02-19
JP2000516258A (ja) 2000-12-05
UY25844A1 (es) 2001-08-27
NO329314B1 (no) 2010-09-27
PE80999A1 (es) 1999-09-06
NO329315B1 (no) 2010-09-27
SK109498A3 (en) 1998-12-02
CY2007014I2 (el) 2009-11-04
CO4940452A1 (es) 2000-07-24
BR9804946A (pt) 1999-08-24
CO4940448A1 (es) 2000-07-24
LU91345I9 (cs) 2018-12-31
KR19990087836A (ko) 1999-12-27
US6740669B1 (en) 2004-05-25
AR012945A1 (es) 2000-11-22
NL300284I2 (nl) 2007-11-01
IL125733A0 (en) 1999-04-11
DK0994863T3 (da) 2003-05-26
AU8437298A (en) 1998-12-30
SK109398A3 (en) 1998-12-02
CN1298708C (zh) 2007-02-07
NZ331371A (en) 2000-08-25
CN1217716A (zh) 1999-05-26
DK0994864T3 (da) 2003-07-21
CZ253498A3 (cs) 1999-04-14
US7750028B2 (en) 2010-07-06
TR199801630T1 (xx) 1999-06-21
CA2256013C (en) 2007-10-16
HU226107B1 (en) 2008-04-28
HK1028241A1 (en) 2001-02-09
KR19990087835A (ko) 1999-12-27
JP2000516259A (ja) 2000-12-05
HUP0000798A2 (hu) 2000-10-30
TW526195B (en) 2003-04-01
CA2614926C (en) 2010-02-09
PL191943B1 (pl) 2006-07-31
JP3672575B2 (ja) 2005-07-20
HU225153B1 (en) 2006-07-28
AR061005A2 (es) 2008-07-30
ATE232852T1 (de) 2003-03-15
CZ292260B6 (cs) 2003-08-13
MY120156A (en) 2005-09-30
ZA984966B (en) 1999-01-11
CZ292481B6 (cs) 2003-09-17
HK1028031A1 (en) 2001-02-02
SI0994863T1 (en) 2003-08-31
DE69811500T2 (de) 2004-04-01
CA2256013A1 (en) 1998-12-17
CN1572789A (zh) 2005-02-02
SI0994864T1 (en) 2003-10-31
DE69813560T2 (de) 2004-02-05
EP0994864A1 (en) 2000-04-26
WO1998056772A1 (en) 1998-12-17
SK283734B6 (sk) 2003-12-02
WO1998056773A1 (en) 1998-12-17
SK283685B6 (sk) 2003-12-02
PT994864E (pt) 2003-07-31
LU91345I2 (fr) 2007-09-04
CZ253398A3 (cs) 1999-04-14
EP0994863A1 (en) 2000-04-26
TR199801631T1 (xx) 1999-06-21
US20040167186A1 (en) 2004-08-26
RU2194041C2 (ru) 2002-12-10
BR9804947A (pt) 1999-08-24
KR100409168B1 (ko) 2004-01-31
NO983666D0 (no) 1998-08-11
NZ331370A (en) 2000-08-25
ES2197485T3 (es) 2004-01-01
IL125733A (en) 2002-12-01
IL125732A (en) 2002-12-01
AU725528B2 (en) 2000-10-12
CA2614926A1 (en) 1998-12-17
DE69813560D1 (de) 2003-05-22
US8076362B2 (en) 2011-12-13
NL300284I1 (nl) 2007-10-01
NO983667D0 (no) 1998-08-11
AU8437198A (en) 1998-12-30
HUP0000798A3 (en) 2000-10-30
NO983667L (no) 1998-12-17
FR07C0037I1 (cs) 2007-08-17
DE69811500D1 (de) 2003-03-27
IL125732A0 (en) 1999-04-11
PL192114B1 (pl) 2006-08-31
DE122007000051I1 (de) 2007-11-08
US6455556B2 (en) 2002-09-24
FR07C0037I2 (cs) 2008-05-16
ES2192779T3 (es) 2003-10-16
PE79799A1 (es) 1999-09-03
US20010037029A1 (en) 2001-11-01
TW403740B (en) 2000-09-01
RU2198167C2 (ru) 2003-02-10
ID27660A (id) 2001-04-19
HK1028242A1 (en) 2001-02-09
CY2007014I1 (el) 2009-11-04
HUP0002113A2 (hu) 2001-02-28
CN1259127A (zh) 2000-07-05
US20100310655A1 (en) 2010-12-09
PL330764A1 (en) 1999-05-24
HUP0002113A3 (en) 2002-09-30
PL330798A1 (en) 1999-06-07
CA2256015A1 (en) 1998-12-17
AU725517B2 (en) 2000-10-12
MY125854A (en) 2006-08-30
US20060116520A1 (en) 2006-06-01
KR100425656B1 (ko) 2004-05-17
CN1132820C (zh) 2003-12-31
ATE237599T1 (de) 2003-05-15
US20030125568A1 (en) 2003-07-03
CN1159300C (zh) 2004-07-28
AR012946A1 (es) 2000-11-22
CA2256015C (en) 2008-06-03
ZA984967B (en) 1999-01-11
NO983666L (no) 1998-12-17
AR061004A2 (es) 2008-07-30
JP3672574B2 (ja) 2005-07-20

Similar Documents

Publication Publication Date Title
ID28779A (id) BENTUK-BENTUK KRISTAL DARI EtO2C-CH2-(R)CgL-Aze-Pab-OH
ID25534A (id) Glucagon-seperti kristal peptida-1
DE69835976D1 (de) Polarisationsunabhängiger optischer Phasenmodulator
DE69528095D1 (de) Optischer, räumlicher Flüssigkristall-Phasenmodulator
ATE331719T1 (de) Verwendung von kristallformen von 2- methylthienobenzodiazepinen
ID25629A (id) AMINA BISIKLIK (Pecahan dari P-961362)
ID20954A (id) Aparat tampilan kristal cair tipe-projeksi
DE69637044D1 (de) Mittel zur orientierung von flüssigkristallen
NO331016B1 (no) Krystallmodifikasjon av et N-fenyl-2-pyrimidinaminderivat
ID27660A (id) Modifikasi kristal dari zat farmasi
FI972292A0 (fi) Administrering av diabetes
DE69622504D1 (de) Flüssigkristallprojektor
DE69628544D1 (de) Flüssigkristall-lichtverschluss
DE69826244D1 (de) Programmierbarer kristalloszillator
DE69833534D1 (de) Flüssigkristallfarbprojektor
DE60033896D1 (de) Unterscheidung von Modulationsarten
NO963049L (no) Modulatorer av forankrende proteinfunksjon
ATE196764T1 (de) Kristallform von 5-methylisoxazol-4-carbonsäure- (4-trifluormethyl)-anilid
NO980287D0 (no) Optiske enkeltsidebåndsmodulatorer
ID19410A (id) Zat pembantu pemutihan (pecahan dari p-940903)
DE69526586D1 (de) Linsenkapselspreizer
DK0966293T3 (da) Lægemiddel til fremme af sårheling indeholdende thrombocytter
DE69612725D1 (de) Kristallhaltevorrichtung
ID18156A (id) Produk farmasi kristal
ID21650A (id) Suspensi farmasi yang terdiri dari nevirapin hemihidrat